Old Port Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Old Port Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,050	Closed	-$626K	–	223
2022 Q2	$626K	Hold	1,050	–	–	0.24%	123
2022 Q1	$730K	Hold	1,050	–	–	0.25%	114
2021 Q4	$628K	Hold	1,050	–	–	0.21%	125
2021 Q3	$574K	Hold	1,050	–	–	0.21%	129
2021 Q2	$610K	Hold	1,050	–	–	0.22%	125
2021 Q1	$497K	Buy	1,050 +430	+69%	+$209K	0.2%	119
2020 Q4	$299K	Buy	+620	New	+$335K	0.13%	147

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Old Port Advisors's REGN Position: Q3 2022 in Review

Old Port Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 1,050 shares — an estimated $626K sold.

Old Port Advisors first reported a position in REGN in Q4 2020 and held it in 7 quarters. The position peaked at $730K in Q1 2022. 1,080 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

Old Port Advisors reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Old Port Advisors sold 1,050 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $626K.
Old Port Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Old Port Advisors's Regeneron Pharmaceuticals position peaked at $730K in Q1 2022.
1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Old Port Advisors's 13F filing for Q3 2022, filed 13 Oct 2022.